Niyoshi joined SV in 2020 as an Associate in the the Dementia Discovery Fund team, to help form and fund companies developing transformational new medicines for dementia.
Niyoshi carries out due diligence of new deals, and provides strategic, BD, and operational support to existing companies in the DDF portfolio supporting them in bringing drugs from discovery to market.
Prior to joining SV/DDF, Niyoshi was a Senior Manager of Business Development at Purdue Pharma, where she worked with the management team to evaluate a number of opportunities in various therapeutic areas. In addition, Niyoshi worked at Prevail Therapeutics and bluebird bio during business school, where she assisted the companies on various strategic and business development initiatives.
Before joining Purdue, Niyoshi worked as an investment professional at Athyrium Capital and Great Point Partners, where she assisted in sourcing, diligence, and execution of various investment opportunities across the healthcare spectrum. Notably, Niyoshi sourced and evaluated Softbox Systems and Clover Health.
Outside of SV/DDF, Niyoshi enjoys live music, running, and travel. Despite her love of Boston, Niyoshi remains loyal to Philadelphia sports teams.